Dual Subsartorial Versus Adductor Canal Block Versus Femoral Nerve Block for Postoperative Analgesia in Patients Undergoing Total Knee Arthroplasty
NCT ID: NCT07082374
Last Updated: 2025-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2025-07-24
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Adductor Canal Block for Total Knee Arthroplasty Analgesia
NCT02387021
Pain Management After Total Knee Replacement
NCT05249478
Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty
NCT06837844
Femoral Triangle Block: Early Mobilization and Postoperative Analgesia After Total Knee Arthroplasty
NCT03518450
Femoral Triangle and Adductor Canal Blocks Versus Femoral Nerve Block for Total Knee Arthroplasty
NCT03645954
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Adductor canal block (ACB) is a common analgesic intervention for postoperative pain control following TKA. The dual subsartorial block (DSB) is a novel procedure-specific and motor-sparing regional analgesia (RA) technique that may reduce overall postoperative opioid consumption when used in conjunction with multimodal analgesia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DSB group
Patients will receive dual subsartorial block (DSB).
Dual subsartorial block
Patients will receive dual subsartorial block (DSB).
ACB group
Patients will receive an adductor canal block (ACB).
Adductor canal block
Patients will receive an adductor canal block (ACB).
FNB group
Patients will receive a femoral nerve block (FNB).
Femoral nerve block
Patients will receive a femoral nerve block (FNB).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dual subsartorial block
Patients will receive dual subsartorial block (DSB).
Adductor canal block
Patients will receive an adductor canal block (ACB).
Femoral nerve block
Patients will receive a femoral nerve block (FNB).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both sexes.
* American Society of Anesthesiology (ASA) physical status I-II.
* Undergoing total knee arthroplasty (TKA) under general anesthesia.
Exclusion Criteria
* Acute/chronic kidney disease.
* Neurological deficit.
* Cognitive dysfunction.
* Local infection at the site of injection.
* Coagulopathy.
* Hypersensitivity and/or allergies to local anesthetic (LA) or any of the study medications.
* Chronic opioid consumption (daily or almost daily use of opioids for \> three months).
* Operative limb neuropathy.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammed Said ElSharkawy
Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta University
Tanta, El-Gharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
36264PR1260/6/25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.